These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 8406186)
21. Effects of interferon-beta on steroid receptors, prostaglandins and enzymatic activities in human endometrial cancer. De Cicco Nardone F; Rossiello F; Iacopino F; Benedetto MT; Cinque B; Dell'Acqua S; Sica G Anticancer Res; 1996; 16(1):161-9. PubMed ID: 8615603 [TBL] [Abstract][Full Text] [Related]
22. Progesterone: the ultimate endometrial tumor suppressor. Yang S; Thiel KW; Leslie KK Trends Endocrinol Metab; 2011 Apr; 22(4):145-52. PubMed ID: 21353793 [TBL] [Abstract][Full Text] [Related]
23. Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer. Yamazawa K; Hirai M; Fujito A; Nishi H; Terauchi F; Ishikura H; Shozu M; Isaka K Hum Reprod; 2007 Jul; 22(7):1953-8. PubMed ID: 17449880 [TBL] [Abstract][Full Text] [Related]
24. [Hormone therapy of endometrial carcinoma]. Kuramoto H; Jobo T; Kato Y; Tateoka K; Sato R Gan To Kagaku Ryoho; 1996 May; 23(6):673-7. PubMed ID: 8645016 [TBL] [Abstract][Full Text] [Related]
25. Immunological evidence for progesterone and estradiol receptors in the freshwater crayfish Austropotamobius pallipes. Paolucci M; Di Cristo C; Di Cosmo A Mol Reprod Dev; 2002 Sep; 63(1):55-62. PubMed ID: 12211061 [TBL] [Abstract][Full Text] [Related]
26. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions]. Ma XX; Zhang SL; Gao S; Lu JM; Dong F Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363 [TBL] [Abstract][Full Text] [Related]
27. Nuclear beta-catenin is a molecular feature of type I endometrial carcinoma. Scholten AN; Creutzberg CL; van den Broek LJ; Noordijk EM; Smit VT J Pathol; 2003 Nov; 201(3):460-5. PubMed ID: 14595758 [TBL] [Abstract][Full Text] [Related]
28. Interferon-beta can induce progesterone receptors in human endometrial adenocarcinoma. Codegoni AM; Landoni F; Lomonico S; Losa G; Mangioni C; Taverna M; Lucchini V; D'Incalci M Cancer; 1996 Aug; 78(3):448-53. PubMed ID: 8697390 [TBL] [Abstract][Full Text] [Related]
29. Cytoplasmic receptors for 17 beta-estradiol, 5 alpha-dihydrotestosterone and progesterone in normal and abnormal human uterine tissues. Grilli S; Ferreri AM; Gola G; Rocchetta R; Orlandi C; Prodi G Cancer Lett; 1977 Mar; 2(4-5):247-58. PubMed ID: 45727 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of in vivo and in vitro responses of endometrial adenocarcinoma to progestins. Holinka CF; Deligdisch L; Deppe G; Fleming H; Namit C; de la Pena MM; Gurpide E Adv Exp Med Biol; 1981; 138():365-76. PubMed ID: 6211063 [No Abstract] [Full Text] [Related]
31. [Features of the endometrial steroid receptor system in habitual abortion with high risk of infectious complications]. Demidova EM; Alekseeva ML; Novikov EA; Ezhova LS; Ankirskaia AS; Zemlianaia AA Akush Ginekol (Mosk); 1991 Sep; (9):10-2. PubMed ID: 1746687 [TBL] [Abstract][Full Text] [Related]
33. Characterisation of a human endometrial adenocarcinoma established in vivo and in vitro. Karlsson L; Leser G; Ryd W; Delle U; Köpf I; Horvath G In Vivo; 1996; 10(4):421-8. PubMed ID: 8839789 [TBL] [Abstract][Full Text] [Related]
34. Molecular tools to reestablish progestin control of endometrial cancer cell proliferation. Dai D; Kumar NS; Wolf DM; Leslie KK Am J Obstet Gynecol; 2001 Apr; 184(5):790-7. PubMed ID: 11303185 [TBL] [Abstract][Full Text] [Related]
35. Epithelial and stromal estrogen and progesterone receptor expression in endometrial cancer: true color computer-assisted image analysis versus subjective scoring. Kohlberger PD; Kieback DG; Breitenecker F; Loesch A; Gitsch G; Kainz C; Breitenecker G Gynecol Oncol; 1997 Mar; 64(3):404-10. PubMed ID: 9062141 [TBL] [Abstract][Full Text] [Related]
36. [Should immunohistochemistry be used to evaluate estrogen and progesterone receptors in breast cancers?]. Balaton AJ; Zafrani B Ann Pathol; 1996; 16(2):78-80. PubMed ID: 8767672 [No Abstract] [Full Text] [Related]
37. Up-regulation of nuclear receptor corepressor (NCoR) in progestin-induced growth suppression of endometrial hyperplasia and carcinoma. Kashima H; Horiuchi A; Uchikawa J; Miyamoto T; Suzuki A; Ashida T; Konishi I; Shiozawa T Anticancer Res; 2009 Apr; 29(4):1023-9. PubMed ID: 19414341 [TBL] [Abstract][Full Text] [Related]
38. Natural interferon-beta treatment and steroid hormone receptors in primary endometrial cancer. Sica G; Iacopino F; Lama G; Marchetti P; Carenza L; Dell'Acqua S; De Cicco Nardone F; Lombardi A; Mariani L; Villani C Gynecol Oncol; 1993 Aug; 50(2):185-90. PubMed ID: 8375733 [TBL] [Abstract][Full Text] [Related]
39. [The significance of Barr's chromatin in carcinoma of the breast]. Zanoio L; Zacché G; Bulgarelli P; Barcellona E; Scanagatta A Minerva Ginecol; 1984; 36(7-8):403-6. PubMed ID: 6493571 [No Abstract] [Full Text] [Related]
40. [Hormonal receptors in metastatic adenocarcinoma of unlocalized primary cancer]. Vannetzel JM; Colbert N; Agnes E; Caillens G; Misrahi M; Renaud J; Roland J; Izrael V; Schlienger M; Laugier A Presse Med; 1985 Mar; 14(10):598. PubMed ID: 3157943 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]